Try our Advanced Search for more refined results

CellCyte CEO Fraud Claims Can Move Forward

By Erin Marie Daly (April 29, 2010, 2:53 PM EDT) -- CellCyte Genetics Corp.'s former CEO has lost his bid to throw out U.S. Securities and Exchange Commission claims related to allegedly fraudulent statements that inflated the company's stock price, but the judge has ordered the agency to get more specific about its claims....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!